These are the 300 companies whose success goes beyond profits to include employee and customer sentiment, cybersecurity, ...

As Vertex Pharmaceuticals Inc. heads toward the end of 2024, the Boston drugmaker is gearing up for two potential drug ...

Ken's career includes key leadership roles in organizations such as the Ontario Government, Victoria University (Toronto), Brock University, Cystic Fibrosis Canada, and Vertex Pharmaceuticals. His ...

Featured Earnings Vertex Pharmaceuticals ...

As the sun rises over the vibrant skyline of Boston, it illuminates not just a beautiful city, but also one of the most ...

Moderna and Vertex Pharmaceuticals, two of the biggest biotechnology ... from the state in exchange for pledges to create 645 local jobs between them. Governor Maura Healey and the quasi-public ...

A Bicester School Sixth Form student "rediscovered her love of learning" earlier this year following a summer internship at ...

She previously led clinical development programs in cystic fibrosis and multiple sclerosis at Vertex and Biogen ... subject to the employee’s continued employment with the Company on each such date.

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

The biotech industry in Boston is more than just a source of jobs or a pillar of the local economy; it is a powerful force in the global fight for better health. Known for its prestigious universities ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in Massachusetts. Moderna and Vertex received the largest awards and will add over ...

Johnson is co-founder of Boston-based Affinia Therapeutics and former CEO of UK biopharma Adrestia Therapeutics Kesmalea's SELFTAC® platform is designed to solve the 'size problem' of large, bifunctio ...